公司资料
Paragon 28 股价、新闻与催化剂
- 股票代码:
- FNA
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for FNA.
公司概览
业务概览
Paragon 28 is a foot-and-ankle orthopedic device company focused on specialized surgical implants and instrumentation. The company’s strategy centers on procedure growth and surgeon adoption.
所在地与行业分类
Headquartered in the United States and listed on NYSE, Paragon 28 sits in procedure-driven medtech.
商业模式特征
Its economics depend on surgical adoption, product launches, and the growth of the foot-and-ankle franchise.
生物医药行业定位
Paragon 28 is a niche orthopedic device company whose valuation is driven more by procedure execution than by biotech-style catalysts.
未来催化剂
- Paragon 28's catalysts are foot-and-ankle implant adoption and continued surgeon penetration in a niche orthopedic market. The company needs more repeatable procedural share to keep re-rating.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。